4.8 Article

A systematic RNAi synthetic interaction screen reveals a link between p53 and snoRNP assembly

期刊

NATURE CELL BIOLOGY
卷 13, 期 7, 页码 809-U186

出版社

NATURE RESEARCH
DOI: 10.1038/ncb2264

关键词

-

资金

  1. MaxPlanckSociety
  2. German Federal Ministry of Education and Research [Go-Bio (0315105), DiGtoP (01GS0859)]
  3. DFG [SFB655]

向作者/读者索取更多资源

TP53 (tumour protein 53) is one of the most frequently mutated genes in human cancer and its role during cellular transformation has been studied extensively. However, the homeostatic functions of p53 are less well understood. Here, we explore the molecular dependency network of TP53 through an RNAi-mediated synthetic interaction screen employing two HCT116 isogenic cell lines and a genome-scale endoribonuclease-prepared short interfering RNA library. We identify a variety of TP53 synthetic interactions unmasking the complex connections of p53 to cellular physiology and growth control. Molecular dissection of the TP53 synthetic interaction with UNRIP indicates an enhanced dependency of TP53-negative cells on small nucleolar ribonucleoprotein (snoRNP) assembly. This dependency is mediated by the snoRNP chaperone gene NOLC1(also known as NOPP140), which we identify as a physiological p53 target gene. This unanticipated function of TP53 in snoRNP assembly highlights the potential of RNAi-mediated synthetic interaction screens to dissect molecular pathways of tumour suppressor genes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin

Dragomir B. Krastev, Shudong Li, Yilun Sun, Andrew Wicks, Gwendoline Hoslett, Daniel Weekes, Luned M. Badder, Eleanor G. Knight, Rebecca Marlow, Mercedes Pardo Calvo, Lu Yu, Tanaji T. Talele, Jiri Bartek, Jyoti Choudhary, Yves Pommier, Stephen J. Pettitt, Andrew Tutt, Kristijan Ramadan, Christopher J. Lord

Summary: The study reveals the regulatory mechanism of trapped PARP1, which is undergoes SUMOylation and ubiquitylation, leading to the recruitment of p97 ATPase for the removal of trapped PARP1 from chromatin and prevention of PARP inhibitor-induced cytotoxicity. Inhibitors targeting p97-complex prolong the trapping of PARP1, enhancing the cytotoxicity of PARP inhibitors in certain types of tumor cells.

NATURE CELL BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Pairing of single mutations yields obligate Cre-type site-specific recombinases

Jenna Hoersten, Gloria Ruiz-Gomez, Felix Lansing, Teresa Rojo-Romanos, Lukas Theo Schmitt, Jan Sonntag, M. Teresa Pisabarro, Frank Buchholz

Summary: This study discovers that paired mutations targeting residues involved in catalysis can create simple and obligate tyrosine site-specific recombinase (SSR) systems, where catalytic activity is dependent on the binding of all distinct subunits as a heterotetramer. This research improves the recombination specificity of designer-recombinases for therapeutic targets and enhances our understanding of SSR catalysis.

NUCLEIC ACIDS RESEARCH (2022)

Article Multidisciplinary Sciences

Correction of a Factor VIII genomic inversion with designer-recombinases

Felix Lansing, Liliya Mukhametzyanova, Teresa Rojo-Romanos, Kentaro Iwasawa, Masaki Kimura, Maciej Paszkowski-Rogacz, Janet Karpinski, Tobias Grass, Jan Sonntag, Paul Martin Schneider, Ceren Gunes, Jenna Hoersten, Lukas Theo Schmitt, Natalia Rodriguez-Muela, Ralf Knofler, Takanori Takebe, Frank Buchholz

Summary: In this study, a dual designer-recombinase system (RecF8) was developed and shown to efficiently correct the common 140 kb inversion found in patients with severe Hemophilia A.

NATURE COMMUNICATIONS (2022)

Article Oncology

Loss of USP28 and SPINT2 expression promotes cancer cell survival after whole genome doubling

Sara Vanessa Bernhard, Katarzyna Seget-Trzensiok, Christian Kuffer, Dragomir B. Krastev, Lisa-Marie Stautmeister, Mirko Theis, Kristina Keuper, Jan-Eric Boekenkamp, Maik Kschischo, Frank Buchholz, Zuzana Storchova

Summary: Our study identified 140 genes that when depleted, improved the survival of tetraploid cells. We characterized two of these genes, SPINT2 and USP28, which play roles in regulating CDKN1A transcription and centrosome clustering, respectively. The results suggest that increased mitogenic signaling, establishment of functional bipolar spindles, and reduced DNA damage signaling contribute to the survival of tetraploid cells.

CELLULAR ONCOLOGY (2022)

Article Biochemistry & Molecular Biology

Conformational dynamics promotes disordered regions from function-dispensable to essential in evolved site-specific DNA recombinases

Carla Guillen-Pingarron, Pedro M. Guillem-Gloria, Anjali Soni, Gloria Ruiz-Gomez, Martina Augsburg, Frank Buchholz, Massimiliano Anselmi, M. Teresa Pisabarro

Summary: Protein intrinsically disordered regions (IDRs) play crucial roles in molecular recognition and regulation. By investigating the disordered N-terminal tail of Cre enzyme, the study provides mechanistic insights into the relationship between structural disorder and protein function. The findings offer new understanding of the functional implications of IDRs and their potential applications in biotechnology and genomic medicine.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)

Article Cell & Tissue Engineering

Antigen presentation safeguards the integrity of the hematopoietic stem cell pool

Pablo Hernandez-Malmierca, Dominik Vonficht, Alexandra Schnell, Hannah J. Uckelmann, Alina Bollhagen, Mohamed A. A. Mahmoud, Sophie-Luise Landua, Elise van der Salm, Christine L. Trautmann, Simon Raffel, Florian Gruenschlaeger, Raphael Lutz, Michael Ghosh, Simon Renders, Nadia Correia, Elisa Donato, Karin O. Dixon, Christoph Hirche, Carolin Andresen, Claudia Robens, Paula S. Werner, Tobias Boch, David Eisel, Wolfram Osen, Franziska Pilz, Adriana Przybylla, Corinna Klein, Frank Buchholz, Michael D. Milsom, Marieke A. G. Essers, Stefan B. Eichmueller, Wolf-Karsten Hofmann, Daniel Nowak, Daniel Huebschmann, Michael Hundemer, Christian Thiede, Lars Bullinger, Carsten Mueller-Tidow, Scott A. Armstrong, Andreas Trumpp, Vijay K. Kuchroo, Simon Haas

Summary: Hematopoietic stem and progenitor cells (HSPCs) can effectively eliminate malignant cells through bidirectional interactions with CD4(+) T cells, thereby preventing the onset of hematological cancers.

CELL STEM CELL (2022)

Article Biochemistry & Molecular Biology

Different Effects of RNAi-Mediated Downregulation or Chemical Inhibition of NAMPT in an Isogenic IDH Mutant and Wild-Type Glioma Cell Model

Maximilian Clausing, Doreen William, Matthias Preussler, Julia Biedermann, Konrad Gruetzmann, Susan Richter, Frank Buchholz, Achim Temme, Evelin Schroeck, Barbara Klink

Summary: The IDH1(R132H) mutation in glioma leads to the production of the oncometabolite 2-HG and changes in cellular redox balance. The study reveals that targeting the NAD(+) synthesis pathway is a promising therapeutic strategy in IDH mutant gliomas, but the available NAMPT inhibitors are not suitable for this purpose.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Cell Biology

RNAi-Mediated Screen of Primary AML Cells Nominates MDM4 as a Therapeutic Target in NK-AML with DNMT3A Mutations

Olga Alexandra Sidorova, Shady Sayed, Maciej Paszkowski-Rogacz, Michael Seifert, Aylin Camgoez, Ingo Roeder, Martin Bornhaeuser, Christian Thiede, Frank Buchholz

Summary: DNMT3A mutations are common genetic abnormalities in adult acute myeloid leukemia, and they play a role in leukemic progenitor and stem cell proliferation, as well as AML relapse. Through RNAi screening, we identified MDM4 as a crucial gene for the proliferation of DNMT3A(WT/R882X) AML cells. Inhibition of MDM2/4 using the ALRN-6924 inhibitor can impair the growth of DNMT3A(WT/R882X) primary cells in vitro by inducing cell cycle arrest through upregulation of p53 target genes.
Article Biology

DNA methylation-independent long-term epigenetic silencing with dCRISPR/Cas9 fusion proteins

Li Ding, Lukas Theo Schmitt, Melanie Brux, Duran Sueruen, Martina Augsburg, Felix Lansing, Jovan Mircetic, Mirko Theis, Frank Buchholz

Summary: The expression of promoter-associated sgRNAs and dCas9 fused with KRABd and the transcription repression domain of MeCP2 can lead to long-term gene silencing in mouse embryonic stem cells and human embryonic kidney cells. Surprisingly, this effect is even more pronounced in cells depleted of DNA methyltransferases 3A and 3B.

LIFE SCIENCE ALLIANCE (2022)

Article Oncology

Efficient Correction of Oncogenic KRAS and TP53 Mutations through CRISPR Base Editing

Shady Sayed, Olga A. Sidorova, Alexander Hennig, Martina Augsburg, Catherine P. Cortes Vesga, Moustafa Abohawya, Lukas T. Schmitt, Duran Sueruen, Daniel E. Stange, Jovan Mircetic, Frank Buchholz

Summary: In this study, programmable nucleases and base editors were used for targeted therapy of KRAS mutations, and it was found that base editors could more effectively correct KRAS mutations and also repair other cancer-associated mutations. This approach lays the foundation for personalized precision oncology applications.

CANCER RESEARCH (2022)

Article Oncology

SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance

Marta J. Llorca-Cardenosa, Lauren I. Aronson, Dragomir B. Krastev, Jadwiga Nieminuszczy, John Alexander, Feifei Song, Malgorzata Dylewska, Ronan Broderick, Rachel Brough, Astrid Zimmermann, Frank T. Zenke, Bora Gurel, Ruth Riisnaes, Ana Ferreira, Theodoros Roumeliotis, Jyoti Choudhary, Stephen J. Pettitt, Johann de Bono, Andres Cervantes, Syed Haider, Wojciech Niedzwiedz, Christopher J. Lord, Irene Y. Chong

Summary: The study highlights the potential issue of drug resistance in using ATR inhibitors in gastric cancer, particularly with loss-of-function mutations in SMG8 and SMG9, and suggests that targeting these pathways may enhance the overall effectiveness of ATRi.

CANCER RESEARCH (2022)

Article Multidisciplinary Sciences

Prediction of designer-recombinases for DNA editing with generative deep learning

Lukas Theo Schmitt, Maciej Paszkowski-Rogacz, Florian Jug, Frank Buchholz

Summary: The authors present RecGen, an algorithm for generating designer-recombinases, which was experimentally validated to predict recombinase sequences. This algorithm can accelerate the development of future designer-recombinases, providing a significant contribution to genome engineering.

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Discovery and characterization of novel Cre-type tyrosine site-specific recombinases for advanced genome engineering

Milica Jelicic, Lukas Theo Schmitt, Maciej Paszkowski-Rogacz, Angelika Walder, Nadja Schubert, Jenna Hoersten, Duran Sueruen, Frank Buchholz

Summary: This study develops a systematic computational workflow for annotating putative tyrosine-type site-specific recombinase (Y-SSR) systems and identifies and characterizes eight new naturally occurring Cre-type SSR systems. The activity of these systems is tested in bacterial and mammalian cells, and selectivity profiles are established for both new and established Cre-type SSRs. Potential pseudo-sites and off-targets for Y-SSRs in the human and mouse genome are also identified, providing valuable information for future genome surgery applications.

NUCLEIC ACIDS RESEARCH (2023)

Article Oncology

Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant Ovarian Cancer

Daniel Martin Klotz, Franziska Maria Schwarz, Anna Dubrovska, Kati Schuster, Mirko Theis, Alexander Krueger, Oliver Kutz, Theresa Link, Pauline Wimberger, Stephan Drukewitz, Frank Buchholz, Juergen Thomale, Jan Dominik Kuhlmann

Summary: We established an in vitro model for PARPi-resistant ovarian cancer and found that PARPi-resistant cells exhibit broad cross-resistance to other PARPis and chemotherapeutic drugs regardless of the BRCA1 status. Co-culture experiments showed that PARPi-resistant cells have a disadvantage in proliferation under drug-free conditions but quickly gain dominance under olaparib selection pressure, which can be blocked by ABC-transporter protein inhibitors. Overall, our well-characterized in vitro model is useful for dissecting mechanisms of PARPi resistance and studying the clonal dynamics of PARPi-resistant cells.

CANCERS (2023)

Article Biotechnology & Applied Microbiology

Quantification of evolved DNA-editing enzymes at scale with DEQSeq

Lukas Theo Schmitt, Aksana Schneider, Jonas Posorski, Felix Lansing, Milica Jelicic, Manavi Jain, Shady Sayed, Frank Buchholz, Duran Sueruen

Summary: DEQSeq is a nanopore sequencing approach that enables the rational selection of favorable genome editing enzymes from directed molecular evolution experiments. It streamlines the process of identifying valuable variants for further study and application by capturing full-length sequences, editing efficiencies, and specificities from thousands of evolved enzymes simultaneously.

GENOME BIOLOGY (2023)

暂无数据